Endometrial Intraepithelial Neoplasia, Concurrent Endometrial Cancer and Risk for Pelvic Sentinel Node Metastases
2024

Endometrial Intraepithelial Neoplasia and Cancer Risk

Sample size: 98 publication Evidence: moderate

Author Information

Author(s): Hawez Tabayi, Michele Bollino, Celine Lönnerfors, Jan Persson

Primary Institution: Skåne University Hospital Lund

Hypothesis

What is the incidence of concurrent endometrial cancer in women with endometrial intraepithelial neoplasia and the risk of sentinel node metastases?

Conclusion

The study found that 47% of women with endometrial intraepithelial neoplasia had endometrial cancer, and 6.3% had sentinel lymph node metastases.

Supporting Evidence

  • 47% of women with EIN had endometrial cancer at final histology.
  • 65% of women diagnosed by endometrial biopsy had endometrial cancer.
  • 6.3% of women with EIN had sentinel lymph node metastases.

Takeaway

If a woman has a certain type of abnormal cells in her uterus, there's a good chance she might also have cancer, so doctors need to check carefully.

Methodology

This was a prospective observational study involving 98 women with endometrial intraepithelial neoplasia who underwent robotic surgery and sentinel lymph node dissection.

Potential Biases

Interobserver variability in diagnosing endometrial intraepithelial neoplasia could affect results.

Limitations

The study may not include all women with EIN as some may have undergone surgery at local hospitals.

Participant Demographics

Women with a mean age of 64 years, with a range from 31 to 86 years.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3390/cancers16244215

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication